VYNE Therapeutics
VYNE
#9857
Rank
NZ$37.39 M
Marketcap
$2.46
Share price
1.39%
Change (1 day)
-44.40%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -$18.13

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$18.59. In 2022 the company made an earnings per share (EPS) of -$12.34 an increase over its 2021 EPS that were of -$43.64.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$18.1346.88%
2022-$12.34-71.72%
2021-$43.64-84.19%
2020-$276.11-26.29%
2019-$374.6128.75%
2018-$290.9610.79%
2017-$262.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.67-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA